~53 spots leftby Dec 2026

Wearable Devices for Type 2 Diabetes (MPowerHub Trial)

Recruiting in Palo Alto (17 mi)
Overseen ByAnn-Marie Rosland, MD, MS
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Ann-Marie Rosland
No Placebo Group

Trial Summary

What is the purpose of this trial?Day-to-day self-management by adults with type 2 diabetes, including glucose monitoring, taking medications, and healthy habits, is essential to avoid diabetes complications, yet, despite the rapidly expanding availability of wearable glucose and activity monitors, successful self-management remains challenging for many. This research aims to develop and test an approach to help adults use their personal diabetes information from wearable devices to achieve and sustain health diabetes self-management, which will reduce diabetes complications, and improve health and quality of life for people with type 2 diabetes.

Eligibility Criteria

This trial is for adults with type 2 diabetes who need help managing their condition. Participants should be interested in using wearable devices like glucose and activity monitors to track their health data.

Inclusion Criteria

I have been diagnosed with type 2 diabetes.
I am taking medication for diabetes that is not insulin.

Exclusion Criteria

I have been diagnosed with diabetes during pregnancy only.
I have been diagnosed with type 1 diabetes.
I was diagnosed with type 2 diabetes before I turned 21.
I am currently taking insulin.
I have a severe illness that limits my life expectancy.

Participant Groups

The study tests the MPowerHub system, which helps participants use data from wearables like Continuous Glucose Monitors (CGM) and Activity Monitors to manage diabetes more effectively.
3Treatment groups
Experimental Treatment
Active Control
Group I: MPowerHubExperimental Treatment3 Interventions
Participants will: 1. Meet with a Diabetes Care and Education Specialist for an initial diabetes self-management education session that will include individualized assessment, education, and coaching on how to set personal diabetes self-management behavior goals and action plans, and follow-up education as needed. 2. Be trained on how to use assigned study devices (MPowerHub, continuous glucose monitor (CGM), and activity tracker). 3. Be asked to use assigned study devices (MPowerHub, CGM, and activity tracker) for 4 months.
Group II: Continuous Glucose Monitor (CGM) OnlyActive Control1 Intervention
Participants will: 1. Meet with a Diabetes Care and Education Specialist for an initial diabetes self-management education session that will include individualized assessment, education, and coaching on how to set personal diabetes self-management behavior goals and action plans, and follow-up education as needed. 2. Be trained on how to use assigned study device (CGM). 3. Be asked to use assigned study device (CGM) for 4 months.
Group III: Activity Monitor OnlyActive Control1 Intervention
Participants will: 1. Meet with a Diabetes Care and Education Specialist for an initial diabetes self-management education session that will include individualized assessment, education, and coaching on how to set personal diabetes self-management behavior goals and action plans, and follow-up education as needed. 2. Be trained on how to use assigned study device (activity tracker). 3. Be asked to use assigned study device (activity tracker) for 4 months.

Find A Clinic Near You

Research locations nearbySelect from list below to view details:
University of PittsburghPittsburgh, PA
Loading ...

Who is running the clinical trial?

Ann-Marie RoslandLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
The Pittsburgh FoundationCollaborator

References